Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹251.19 Cr |
| Fresh Issue | ₹165.00 Cr |
| Offer for Sale | ₹86.19 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹210.00-221.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 544138 |
| NSE Code | JGCHEM |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Keynote Financial Services Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 67 shares and in multiples thereof
JG Chemicals Limited was founded in 1975 and is a zinc oxide manufacturer using the French process. The company produces more than 80 grades of zinc oxide.
This product is used in various industrial applications such as ceramics, paints and coatings, pharmaceuticals and cosmetics, electronics and batteries, agrochemicals and fertilizers, specialty chemicals, lubricants, oil and gas, and animal feed.
The company operates three manufacturing facilities in Jangalpur and Belur, both in Kolkata, West Bengal and Naidupeta in Nellore District, Andhra Pradesh. Naidupeta is the largest facility, owned and operated by the Material subsidiary. All manufacturing facilities are ISO 45001:2018 and ISO 14001:2015 certified and ISO 9001:2015 accredited.
The company has served the needs of more than 200 local and 50 international customers in more than 10 countries.
As of December 31, 2023, the company employed 112 permanent employees, over 100 workers and apprentices.
For the nine-month period ended December 31, 2023 and the financial years 2023, 2022 and 2021, the Company recorded operating income of ₹ 4,863.22 million, ₹ 7,845.76 million, ₹ 6,128.30 million and ₹ 4,352.98 million respectively.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment or pre-payment, in full or in part, of all or certain borrowings availed by our Material Subsidiary; | 25.00 |
| 2 | Funding capital expenditure requirements for setting up of R&D Centre | 6.06 |
| 3 | Funding its long-term working capital requirements | 60.00 |
| 4 | Funding long-term working capital requirements of our Company | 35.00 |
| 5 | General corporate purposes | 23.27 |
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 271.26 | 297.79 | 264.14 | 209.94 |
| Total Income | 491.10 | 794.19 | 623.05 | 440.41 |
| Profit After Tax | 18.51 | 56.79 | 43.13 | 28.80 |
| NET Worth | 217.86 | 199.89 | 147.66 | 108.48 |
| Reserves and Surplus | 193.22 | 175.67 | 151.23 | 107.17 |
| Amount in ₹ Crore | ||||
| KPI | Dec 31, 2023 |
|---|---|
| ROE | 8.20% |
| ROCE | 11.86 % |
| Debt / Equity | 0.11% |
| RoNW | 8.16% |
| PAT Margin | 7.24% |
| Price to Book Value | 3.51 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 13.60 | 11.01 |
| P/E (x) | 16.25 | 20.08 |
| Promoter Holding | 100.00% | |
| Market Cap | ₹866.01 Cr. | |
Last Updated on 13-May-2026 10:31:45
